FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approves a supplemental application for Quinapril from BluePoint Laboratories, a generic ACE inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Quinapril (quinapril)

Snippet

SUPPL AP for QUINAPRIL (QUINAPRIL)